Paul Matheis

Xcovery Holdings starts Phase I/II trials of oral angiogenesis inhibitor, X-82, for neovascular wet age-related macular degeneration (AMD).

People with vision impairments are more than twice as likely to fall. So Prevent Blindness America (PBA) supports National Falls Prevention Day on the 22nd.